UK markets closed

Medigene AG (0QGJ.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
1.4450-0.0750 (-4.93%)
At close: 04:22PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.91
52-week change 3-21.93%
S&P500 52-week change 326.49%
52-week high 32.2500
52-week low 30.0000
50-day moving average 31.7051
200-day moving average 31.7165

Share statistics

Avg vol (3-month) 3128
Avg vol (10-day) 3144
Shares outstanding 524.56M
Implied shares outstanding 6N/A
Float 823.57M
% held by insiders 12.95%
% held by institutions 13.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.25:1
Last split date 303 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -268.10%
Operating margin (ttm)-295.49%

Management effectiveness

Return on assets (ttm)-24.21%
Return on equity (ttm)-55.69%

Income statement

Revenue (ttm)6.03M
Revenue per share (ttm)0.25
Quarterly revenue growth (yoy)-50.20%
Gross profit (ttm)N/A
EBITDA -15.55M
Net income avi to common (ttm)-16.18M
Diluted EPS (ttm)-0.4060
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)16.67M
Total cash per share (mrq)0.68
Total debt (mrq)2.95M
Total debt/equity (mrq)14.00%
Current ratio (mrq)2.53
Book value per share (mrq)0.86

Cash flow statement

Operating cash flow (ttm)-15.12M
Levered free cash flow (ttm)-6.93M